Determinants of Complementary Therapy Use in HIV-Infected Individuals Receiving Antiretroviral or Anti-opportunistic Agents

Autor: Michael V. O'Shaughnessy, Martin T. Schechter, Michelle J. Ostrow, Kevin J. P. Craib, Peter G. A. Cornelisse, Katherine V. Heath, Julio S. G. Montaner, Robert S. Hogg
Rok vydání: 1997
Předmět:
Zdroj: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 15:115-120
ISSN: 1077-9450
DOI: 10.1097/00042560-199706010-00003
Popis: OBJECTIVE To identify sociodemographic and clinical characteristics of persons using complementary therapy in an HIV/AIDS drug treatment program and to evaluate the associations between complementary therapy use and participant characteristics. METHODS A cross-sectional study using program participants who completed an annual participant survey between 09/95 and 06/96. Surveys gathered data on use and motivations for use of complementary therapies. Complementary therapies included dietary, medicinal, tactile, and relaxation therapies. Statistical analyses were carried out using parametric and nonparametric measures and multivariate logistic analyses. Multivariate modeling considered age, income, education, time spent out of bed, and degree of pain as independent variables against complementary therapy use (Yes versus No). All reported p values are two-sided. RESULTS A total of 657 participants completed an annual participant survey within the study period. Of these, 256 participants (39%) had ever used complementary therapies. Univariate analysis indicated that 195 patients (30%) had used dietary supplements, 141 (22%) had used herbal and other medicinal therapies, 145 (22%) had used tactile therapies, and 128 (20%) had used mental relaxation techniques. Multivariate analysis indicated that complementary use was independently associated with younger median age (p = .003), income >$7,300 U.S. (p = .014), having greater physical pain (p = .003), and a university education (p = .002). CONCLUSION Use of complementary therapies in conjunction with HIV/AIDS medications appears to be most prevalent in young and highly educated individuals and to be associated with the debilitating and chronic nature of HIV disease.
Databáze: OpenAIRE